PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 10 days ago Xenetic Biosciences, Inc. Announces Entry by Collaboration Partner into Clinical Study Agreement to Advance Development of DNase Platform for the Treatment of Large B Cell Lymphoma Xenetic Biosciences collaborates with PeriNess for an exploratory clinical study of DNase I with anti-CD19 CAR T cells in large B cell lymphoma patients at Tel Aviv Sourasky Medical Center Xenetic Biosciences DNase I PeriNess Large B Cell Lymphoma Anti-CD19 CAR T Cells
PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 10 days ago FRP Holdings, Inc. Announces Release Date for Its 2025 Second Quarter Earnings and Details for the Earnings Conference Call FRP Holdings, Inc. (NASDAQ: FRPH) to release Q2 earnings on August 6, 2025, with a conference call on August 7, 2025. Details for access provided. Company involved in real estate business Financial Results Conference Call Earnings Real Estate Business FRP Holdings Inc.
PRESS RELEASE published on 07/30/2025 at 15:00, 11 months 10 days ago Safe & Green Holdings Restructures Recent Transaction, Reducing Dilution and Complies with NASDAQ Panel Requirements Safe & Green Holdings Corp. restructures private placement with D. Boral Capital, cancelling Series A and Series B Warrants to reduce dilution by 70%. Complies with NASDAQ standards Private Placement Restructuring Nasdaq Compliance Safe & Green Holdings Corp. Cancellation Of Warrants
PRESS RELEASE published on 07/30/2025 at 14:50, 11 months 10 days ago Spetz Inc Begins Trading on the OTCQB Exchange Under the Ticker Symbol DBKSF Spetz Inc. (CSE:SPTZ)(OTCQB:DBKSF) uplisted to OTCQB, enhancing U.S. investors' access to Sonic blockchain ecosystem. Company expands digital asset strategy OTCQB Spetz Inc. U.S. Investors Digital Asset Strategy Sonic Blockchain Ecosystem
PRESS RELEASE published on 07/30/2025 at 14:30, 11 months 10 days ago Measles Cases Increasing Worldwide, Need the New NV-387 Broad-Spectrum Antiviral to Combat, Says NanoViricides NanoViricides introduces drug candidate NV-387 as a potential treatment for Measles outbreak. The drug has shown safety and effectiveness in animal studies and Phase I trial, aiming to combat the global epidemic NanoViricides NV-387 Antiviral Vaccination Measles
PRESS RELEASE published on 07/30/2025 at 14:29, 11 months 10 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Medincell's partner Teva Pharmaceuticals raises 2025 revenue outlook for UZEDY® to $190–$200M and confirms Olanzapine LAI on track for submission in 2025 Revenue Outlook Medincell Teva Pharmaceuticals Olanzapine LAI Submission
PRESS RELEASE published on 07/30/2025 at 14:25, 11 months 10 days ago Forward Water Technologies Announces Financial Results for the Fifteen-Month Period Ended March 31, 2025 Forward Water Technologies Corp. (FWTC) releases financial results for the fifteen-month period ended March 31, 2025. CEO discusses successful trial with iFO™ process and plans for technology expansion Financial Results Forward Water Technologies Corp. Technology Expansion IFO™ Process Publicly Traded
PRESS RELEASE published on 07/30/2025 at 14:00, 11 months 10 days ago GameSquare's Stream Hatchet Publishes 2025 Q2 Live Streaming Trends Report Global live streaming viewership grew 5% YoY to 9.1 billion hours in Q2 2025, reaching highest level since 2021, as per Stream Hatchet report by GameSquare Holdings GameSquare Holdings Stream Hatchet Live Streaming Viewership Q2 2025
PRESS RELEASE published on 07/30/2025 at 14:00, 11 months 10 days ago Stabilis Solutions Announces Second Quarter 2025 Conference Call and Webcast Date Stabilis Solutions, Inc. to issue Q2 2025 results on August 6, 2025, with a conference call on August 7, 2025, to discuss financial results and recent events Financial Results Conference Call Investor Relations Stabilis Solutions Q2 2025 Results
PRESS RELEASE published on 07/30/2025 at 14:00, 11 months 10 days ago Nextech3D.AI Reports Audited Financial Results; 55% Gross Profit Growth and 58% Reduction in Operating Cash Burn Nextech3D.AI Corp. announces improved financial results for the 15-month period ended March 31, 2025, showing increased gross profit, margin, and operational efficiencies. CEO Gappelberg highlights margin expansion and recurring revenue growth strategy Financial Results Nextech3D.ai Recurring Revenue AI-powered Solutions Margin Expansion
Published on 07/09/2026 at 18:05, 3 hours 2 minutes ago Sky Gold Corp Reports on Gold and Multi-Element Results from Drilling at Evening Star, Nevada
Published on 07/09/2026 at 16:00, 5 hours 7 minutes ago Karbon-X Expands European Compliance Market Capabilities With Spanish EU ETS Registry Account
Published on 07/09/2026 at 14:00, 7 hours 7 minutes ago GameSquare Signs Dairy MAX as Brand Partner for the World of Dance
Published on 07/09/2026 at 14:00, 7 hours 7 minutes ago Horizon Aircraft Selects BETA Technologies Advanced Flight Control Computers and Software for the Cavorite X7
Published on 07/09/2026 at 19:25, 1 hour 41 minutes ago LIGHTON CHANGES ITS GOVERNANCE WITH THE APPOINTMENT OF JEAN-PHILIPPE BAERT AS CHIEF EXECUTIVE OFFICER AND MARIE DE LAUZON AS CHAIR OF THE BOARD OF DIRECTORS
Published on 07/09/2026 at 18:46, 2 hours 20 minutes ago OHB publishes results of the subscription offer and announces completion of the capital increase
Published on 07/09/2026 at 17:25, 3 hours 41 minutes ago FP Markets: The era of forward guidance coming to an end
Published on 07/09/2026 at 18:00, 3 hours 7 minutes ago Second-quarter 2026 activity: +7% (vs. Q2 2025)
Published on 07/09/2026 at 18:00, 3 hours 7 minutes ago Half-year report on Deezer’s liquidity contract with BNP Paribas
Published on 07/09/2026 at 17:45, 3 hours 22 minutes ago Air Liquide to invest over 200M USD to support chemical manufacturing expansion in Texas
Published on 07/09/2026 at 15:50, 5 hours 16 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of June 30, 2026